Curcumin—no longer merely a culinary spice or folk medicine, but an ingredient with a track record of research-backed health benefits—is set for another big year in 2018.
GOED issued a statement to its members affirming several points, including that the meta-analysis, which showed that omega-3 fatty acid supplementation had no significant associations with CHD death, nonfatal myocardial infarction, any coronary heart disease events, or major vascular events, adds little to the current body of evidence surrounding omega-3s and cardiovascular risk factors.
The company says that its first food-grade potassium chloride facility will help manufacturers lower products' sodium content by up to 50%.
Researchers noted that while surgical and trans catheter aortic valve replacements can treat severe symptomatic calcific aortic valve stenosis cases, not all patients are good candidates for the procedures.
Both formulas deliver 400 mg of turmeric extract standardized to 95% curcuminoids per serving, concentrating the dose of curcumin that consumers receive.
The report has been posted to the Codex Alimentarius Commission website.
The company said that consumers’ failure to correctly identify “bad” cholesterol highlights the importance of consumer education.
A look at why CoQ10 has remained a go-to heart health ingredient for decades.
In its response, the ITC stated that “Amarin’s complaint does not allege an unfair method of competition or an unfair act cognizable under 19 U.S.C. § 1337(a)(1)(A), as required by the statute and the Commission’s rules.”
Recent studies indicate magnesium’s growing importance for mental health, arterial flexibility, and metabolic function.